PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (8) , 3847-3861
Abstract
Rationale: Cell reprogramming technology is utilized to prevent cancer progression by transforming cells into terminally differentiated, non-proliferating states. Polypyrimidine tract binding protein 1 (PTBP1) is an RNA binding protein required for the growth of neurons and may directly transform multiple normal human cells into functioning neurons in vitro and in vivo when expressed at low levels. As a result, we identified it as a key to inhibiting cancer cell proliferation by boosting glioblastoma cell neural differentiation.Keywords
This publication has 55 references indexed in Scilit:
- Neuronal Transcription Factors Induce Conversion of Human Glioma Cells to Neurons and Inhibit TumorigenesisPLOS ONE, 2012
- Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPasesChemistry & Biology, 2012
- Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2Critical Reviews in Biochemistry and Molecular Biology, 2012
- PTBP1‐dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesisMolecular Carcinogenesis, 2011
- The Dependence Receptor UNC5H2/B Triggers Apoptosis via PP2A-Mediated Dephosphorylation of DAP KinaseMolecular Cell, 2010
- Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell linesBrain, 2009
- Unc5B associates with LARG to mediate the action of repulsive guidance moleculeJournal of Cell Biology, 2009
- Role of RhoA in Activity-Dependent Cortical Axon BranchingJournal of Neuroscience, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neuronesJournal of Neurochemistry, 2004